You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東寶生物(300239.SZ)再度大幅回調 新型人造肉合作研發項目尚未實現營業收入和利潤
格隆匯 09-11 10:07
格隆匯9月11日丨繼昨日跌停後,東寶生物(300239.SZ)今日繼續大幅回調,盤中一度逼近跌停,目前跌幅收窄至9%以內;此前該股自8月24日的5.01元開始啟動上漲行情,一度漲至昨日盤中最高價9.85元,期間最大漲幅達96%。公司與包頭輕工職業技術學院進行新型人造肉合作研發的項目,該項目是在現有人造肉研究的基礎上創新升級,目前已完成基礎結構研發,正在進行蛋白質氨基酸組成結構研究,目標是形成符合人體氨基酸結構需求的適合大眾口味的新型人造肉產品。但公司昨晚稱,該項目尚未形成最終市場化產品,尚未實現營業收入和利潤,預計對公司本年經營業績不會產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account